Company Profile

Arta Bioscience Inc
Profile last edited on: 1/8/2024      CAGE: 5XU95      UEI: D4UKCHA4VLG4

Business Identifier: Therapeutics for prostate cancer and inflammatory diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

54 Aberdeen Place
Saint Louis, MO 63105
   (415) 533-7450
Location: Single
Congr. District: 02
County: St. Louis

Public Profile

ARTA Bioscience Inc, founded using technology originally developed at Washington University, is developing new therapeutics for prostate cancer and inflammatory diseases. Current treatments for prostate cancer are insufficient and the disease is the second leading cause of cancer deaths among American men. ARTA's technology involves an entirely different approach to combating disease compared to traditional treatments. In addition to prostate cancer, the company's technologies may be used to target other important proteins in the nuclear receptor class. The company has established operations at the BioGenerator Accelerator Labs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 1 NIH $200,000
Project Title: Tas::75 0849::Tas Topic 255: a Novel; Non-Competitive Androgen Receptor Inhibito

Key People / Management

  Brent Blackburn

  Michelle Call

Company News

There are no news available.